Metraipolis › archive › dc_d72fa7bcef83

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers — Europe PMC PMID:42350451

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42350451
DOI
10.1038/s41523-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-10-31T08:47:02.963Z
SHA-256 of the archived text
29f61efb513f684a1a3378a9d2445a781f0e66719d6f612e6ce0c77aa9e9a139
Stable URL of this page
https://metraipolis.com/documento/dc_d72fa7bcef83

How to cite

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers — Europe PMC PMID:42350451 — Europe PMC (en), https://europepmc.org/article/MED/42350451 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d72fa7bcef83 (Metraipolis archive dc_d72fa7bcef83, sha256 29f61efb513f684a1a3378a9d2445a781f0e66719d6f612e6ce0c77aa9e9a139)
BibTeX
@misc{dcd72fa7bcef83,
  title = {Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers — Europe PMC PMID:42350451},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42350451},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d72fa7bcef83; sha256 29f61efb513f684a1a3378a9d2445a781f0e66719d6f612e6ce0c77aa9e9a139},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42350451. Agents can read the archived copy with the MCP tool read_document.